Endotronics Inc said decision discontinue development health care product , reorganize Chapter 11 establish adequate allowance uncollectible receivables , expects establish reserve totaling 11 mln dlrs March 31 second quarter .
The company said plan seek buyer health care technology including proprietary right Hepatitis B Vaccine technology related LAK cell cancer immunotherapy .
Reuter & # 3 ; 